Synaptogenix Inc. (NASDAQ:SNPX) went up by 19.86% from its latest closing price compared to the recent 1-year high of $14.40. The company’s stock price has collected 8.88% of gains in the last five trading sessions. Press Release reported 14 hours ago that Synaptogenix Announces Conference Call to Discuss AAIC Abstract Findings
Is It Worth Investing in Synaptogenix Inc. (NASDAQ :SNPX) Right Now?
Opinions of the stock are interesting as 0 analysts out of 0 who provided ratings for Synaptogenix Inc. declared the stock was a “buy,” while 0 rated the stock as “overweight,” 0 rated it as “hold,” and 0 as “sell.”
SNPX currently public float of 2.99M and currently shorts hold a 18.37% ratio of that float. Today, the average trading volume of SNPX was 415.44K shares.
SNPX’s Market Performance
SNPX stocks went up by 8.88% for the week, with a monthly jump of 5.62% and a quarterly performance of 16.50%. The volatility ratio for the week stands at 10.45% while the volatility levels for the past 30 days are set at 12.46% for Synaptogenix Inc.. The simple moving average for the period of the last 20 days is 17.47% for SNPX stocks with a simple moving average of 40.30% for the last 200 days.
SNPX Trading at 39.17% from the 50-Day Moving Average
After a stumble in the market that brought SNPX to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -19.10% of loss for the given period.
Volatility was left at 12.46%, however, over the last 30 days, the volatility rate increased by 10.45%, as shares surge +13.99% for the moving average over the last 20 days. Over the last 50 days, in opposition, the stock is trading +66.43% upper at present.
During the last 5 trading sessions, SNPX rose by +8.88%, in comparison to the 20-day moving average, which settled at $9.99. In addition, Synaptogenix Inc. saw 94.17% in overturn over a single year, with a tendency to cut further gains.
Reports are indicating that there were more than several insider trading activities at SNPX starting from Silverman Joshua, who purchase 10,000 shares at the price of $8.30 back on Jun 14. After this action, Silverman Joshua now owns 15,000 shares of Synaptogenix Inc., valued at $83,000 using the latest closing price.
Alkon Daniel L., the Chief Scientific Officer of Synaptogenix Inc., purchase 10,000 shares at $8.26 during a trade that took place back on Jun 14, which means that Alkon Daniel L. is holding 11,484 shares at $82,600 based on the most recent closing price.
Stock Fundamentals for SNPX
The total capital return value is set at -98.92, while invested capital returns managed to touch -112.63.
The liquidity ratio also appears to be rather interesting for investors as it stands at 4.17.